Björnhagen V, Erhardt K, Lagerlöf B, Auer G
Department of Plastic and Reconstructive Surgery, Karolinska Institute and Hospital, Stockholm, Sweden.
Anal Quant Cytol Histol. 1991 Oct;13(5):343-50.
The DNA patterns obtained from 23 primary malignant melanomas and 35 corresponding metastases were compared and found to differ in many cases. In eight cases the primary tumors and their metastases had a ploidy type I ("euploid") DNA pattern. One case had a type I primary tumor and both type I and type II metastases. Five cases had type I primary tumors and ploidy type II ("aneuploid") DNA pattern metastases. In five cases the primary tumors and corresponding metastases were type II, and in another four cases the primary tumors were type II, whereas the metastases were type I. We interpret these data as indicating that malignant melanomas (more often than adenocarcinomas) are composed of genetically heterogeneous tumor sublines that frequently give rise to heterogeneously composed metastases. Since we sometimes observed a change in the DNA content in malignant melanomas, it seems to be more difficult to obtain prognostic information from DNA analysis in malignant melanoma as compared to the more stable adenocarcinomas.
对23例原发性恶性黑色素瘤及其35例相应转移灶的DNA图谱进行比较,发现许多病例存在差异。8例原发性肿瘤及其转移灶具有I型(“整倍体”)DNA图谱。1例原发性肿瘤为I型,转移灶既有I型又有II型。5例原发性肿瘤为I型,转移灶为II型(“非整倍体”)DNA图谱。5例原发性肿瘤及其相应转移灶为II型,另外4例原发性肿瘤为II型,而转移灶为I型。我们将这些数据解释为表明恶性黑色素瘤(比腺癌更常见)由基因异质性的肿瘤亚系组成,这些亚系经常产生异质性组成的转移灶。由于我们有时观察到恶性黑色素瘤中DNA含量的变化,与更稳定的腺癌相比,从恶性黑色素瘤的DNA分析中获取预后信息似乎更困难。